Back to top

Bank of America Securities Reaffirms Their Buy Rating on Neurocrine (NBIX)

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Neurocrine, with a price target of $199.00. Ahm...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Neurocrine Biosciences, Inc. (NBIX)